Operating Cash Flow Yield: 2.83%

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the operating cash flow yield high or low?

The operating cash flow yield of 2.83% is 13% above its estimated 2-year average of 2.50%, around the middle of its estimated 2-year range (1.06%–4.83%).

As of 2026-10-06T19:42:12.519Z. 12.52% above its estimated 12-month average of 2.52%.

KRYS Operating Cash Flow Yield Metrics

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield FAQ

What is the operating cash flow yield for Krystal Biotech, Inc. (KRYS)?

The operating cash flow yield for KRYS stock is 2.83%.

Is Krystal Biotech, Inc.'s operating cash flow yield high or low?

The operating cash flow yield of 2.83% is 13% above its estimated 2-year average of 2.50%, around the middle of its estimated 2-year range (1.06%–4.83%).

What is the estimated TTM average operating cash flow yield for Krystal Biotech, Inc. (KRYS)?

The estimated TTM average operating cash flow yield for KRYS stock is 2.52%.

Showing the most recent 260 of 479 data points. The chart above shows the full history.

Related Metrics